CIK 0001710072
- Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 821725586
- Phone
- +1 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- 4 Open-market sale Chief Business Officer sold 2,491 shares at $13.39 ($33,360)
- 4 Open-market sale Chief Financial Officer sold 1,428 shares at $13.39 ($19,124)
- 4 Open-market sale Chief Scientific Officer sold 1,907 shares at $13.39 ($25,539)
- 4 Open-market sale President and CEO sold 7,972 shares at $13.39 ($106,764)
- 4 Open-market sale CMO sold 2,862 shares at $13.39 ($38,329)
- 4 Grant or award Director acquired 858 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Scientific Officer sold 1,551 shares at $16.45 ($25,520)
- 4 Open-market sale General Counsel sold 1,930 shares at $16.45 ($31,757)
- 4 Open-market sale President and CEO sold 4,276 shares at $16.45 ($70,358)
- 4 Open-market sale CMO sold 5,187 shares at $16.45 ($85,348)
- 4 Open-market sale Chief Business Officer sold 1,691 shares at $16.45 ($27,824)
- 4 Open-market sale Chief Financial Officer sold 1,314 shares at $16.45 ($21,621)
- 4 Open-market buy Director bought 496,771 shares at $20.13 ($10,000,000)
- 4 Open-market buy Director bought 496,771 shares at $20.13 ($10,000,000)
Page 3 of 11 · 203 filings